TABLE 2.
Poor outcome N = 53 |
Favorable outcome N = 92 |
t/X 2/z value | p Value | |
---|---|---|---|---|
Age a (years) | 65.8 ± 10.4 | 60.6 ± 12,8 | −2.487 | .014 |
Men b (n, %) | 37 (69.8%) | 59 (64.1%) | 0.485 | .486 |
NIHSS score on admission c | 11 (7–14) | 6 (4–9) | −4.980 | <.001 |
Hypertension b (n, %) | 37 (69.8%) | 68 (73.9%) | 0.283 | .595 |
Diabetes b (n, %) | 18 (34.0%) | 22 (23.9%) | 1.700 | .192 |
Smokers/ex‐smokers b (n, %) | 15 (28.3%) | 33 (35.9%) | 0.870 | .351 |
Atrial fibrillation b (n, %) | 16 (30.2%) | 18 (19.6%) | 2.114 | .146 |
Previous stroke b (n, %) | 15 (28.3%) | 11 (12.0%) | 6.105 | .013 |
PAT b (n, %) | 8 (15.1%) | 7 (7.6%) | 2.032 | .154 |
OTT a (min) | 209.8 ± 53.5 | 204.4 ± 59.2 | −0.551 | .583 |
BG on admission a (mmol/L) | 7.4 ± 3.0 | 7.1 ± 2.3 | −0.547 | .585 |
SBP on admission a (mm Hg) | 153.6 ± 27.4 | 161.6 ± 24.2 | 1.805 | .073 |
DBP on admission a (mm Hg) | 90.0 ± 17.1 | 93.3 ± 17.4 | 1.102 | .272 |
Stroke subtype b | ||||
LAA (n, %) | 18 (34.0%) | 30 (32.6%) | 4.005 | .261 |
SAO (n, %) | 10 (18.9%) | 30 (32.6%) | ||
CE (n, %) | 16 (30.2%) | 18 (19.6%) | ||
UE (n, %) | 9 (17.0%) | 14 (15.2%) | ||
HT b (n, %) | 21 (39.6%) | 19 (20.7%) | 6.058 | .014 |
SILASO b (n, %) | 26 (49.1%) | 29 (31.5%) | 4.392 | .036 |
ACVS b | ||||
Grade 0 (n, %) | 32 (60.4%) | 78 (84.8%) | 11.321 | .001 |
Grade 1 (n, %) | 1 (1.9%) | 1 (1.1%) | ||
Grade 2 (n, %) | 10 (18.9%) | 8 (8.7%) | ||
Grade 3 (n, %) | 10 (18.9%) | 5 (5.4%) |
Abbreviations: ACVS, asymmetrical cortical vessel sign; BG, blood glucose; CE, cardiaembolism; DBP, diastolic blood pressure; HT, hemorrhagic transformation; LAA, large artery atherosclerosis; NIHSS, National Institutes of Health Stroke Scale; OTT, onset to treatment time; PAT, previous antiplatelet therapy; SAO, small artery occlusion; SBP, systolic blood pressure; SILASO, severe intracranial large artery stenosis or occlusion; UE, unknown etiologies.
Mean(SD),t test.
n (%), chi‐square test.
Mann–Whiteny U test.